Report Highlights
The global market for nebulizers, inhalers and respirators has reached nearly $11.2 billion and $12.4 billion in 2013 and 2014, respectively. This market is expected to grow at compound annual growth rate (CAGR) of 8.9% to reach $19.0 billion in 2019.
Report Includes
- An overview of the global markets for nebulizers, inhalers, and respirators used for Asthma treatment.
- Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
- Analysis of the market based on market share, product types, and geography.
- Information on suppliers of asthmatic equipment and related devices.
- Discussion on important manufacturers, technologies, and factors influencing demand.
- Information pertaining to the industry's dynamics including market drivers, restraints, and opportunities.
SCOPE OF THE STUDY
The report is a comprehensive business tool designed to provide an in-depth look at equipment related to asthma. The report is global in geographical scope, with special emphasis on individual regions. The report describes the industry, its relationship to the healthcare sector, its participants and trends for the future. Categories discussed in the report include:
- Nebulizers.
- Inhalers.
- Respirators.
Factors discussed in the report include:
- Air pollution and its causes and effects.
- Genetics.
- Obesity.
- Other factors related to asthmatic conditions.
The report includes detailed discussion on topics that include description and identification of current products on the market, measuring market size, identification of market drivers and market forecasts from 2014 to 2019. Competitors and their market shares are assessed. At the country level, the market is broken down into segments, with 2013 as the base year and projections to 2019 indicated in data tables. Year-to-year differences are considered statistically insignificant. The market evaluated in the study pertains to existing devices used to treat asthma that are developed and approved for human clinical use. Market size takes into account nebulizers, inhalers and respirators. Options and upgrades and refurbished and remarketed equipment have not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services related to the relief of asthmatic conditions are discussed. Metrics at the country level are used to examine market dynamics and their impact on revenues and growth. Interviews were used to confirm and/or adjust market size and market share estimates as well as formulating market projections.
ANALYST’S CREDENTIALS
Smruti Munshi is a research analyst who has specialized in medical technologies for the last five years. She focuses on monitoring and analyzing emerging trends and technologies, competitive benchmarking and market dynamics within the medical devices industry. Smruti has worked on several projects spanning the Europe, Middle East and Africa markets, ranging from market insights and industry reviews to comprehensive marketing and technology-oriented custom consulting. She has an M.S. in biomedical engineering and a B.S. in instrumentation and control engineering.
Related Reports
Anesthesia and Respiratory Devices: Global Markets
The global market for anesthetic and respiratory devices reached $11.1 billion in 2012. This market is expected to grow to $12.4 billion in 2013 and $19.6 billion in 2018 with a compound annual growth rate (CAGR) of 9.5% for the five-year period, 2013 to 2018.
Global Markets for Asthma and COPD Drugs
The global market for asthma and chronic obstructive pulmonary disease (COPD) prescription drugs was valued at $34.9 billion in 2011. This figure is projected to reach $38 billion in 2012 and $47.1 billion in 2017, increasing at a five-year compound annual growth rate (CAGR) of 4.4%.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More